INSUBCONTINENT EXCLUSIVE:
to subscription data on the stock exchanges
The diagnostic chain's IPO opened for bidding on Wednesday, September 1, and will close tomorrow, September 3, remaining open for investors
Diagnostics will not get any proceeds from the issue
Further, the company has a huge concentration catering to just 2 states in South India
The competition has increased as many players are getting into this business post covid pandemic.At the higher end of the price band, Vijaya
Diagnostic Centre IPO is priced at a P/E ratio of ~64 times FY21 EPS (on a fully diluted on post-issue basis)
This is lower compared to listed peers Dr Lal Path Labs (110 times), and Metropolis Healthcare (81 times)
investment advisor said in a report
